Modern aspects of acne pathogenesis;Moderne aspekte der aknepathogenese

JDDG - Journal of the German Society of Dermatology

Volumn 8, Issue SUPPL. 1, 2010, Pages

  Zouboulis, Christos C ^a  

^a DESSAU MEDICAL CENTER   (Germany)

Author keywords

Acne; Androgens; Bacteria; Environmental factors; Neuropeptides; Pathogenesis; PPAR

Indexed keywords

ANDROGEN; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 8; LIPID; NEUROPEPTIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; SUBSTANCE P; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; BACTERIAL ANTIGEN;

ACNE VULGARIS; ARTICLE; COMEDO; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; INFLAMMATION; LIPOGENESIS; PATHOGENESIS; PROPIONIBACTERIUM ACNES; SEBACEOUS GLAND; ADOLESCENT; ADULT; BLOOD; CROSS-SECTIONAL STUDY; FEMALE; GENETICS; MALE; PATHOGENICITY; PREGNANCY; RISK FACTOR; SOCIAL ENVIRONMENT; TWINS; YOUNG ADULT;

ACNE VULGARIS; ADOLESCENT; ADULT; ANDROGENS; ANTIGENS, BACTERIAL; CROSS-SECTIONAL STUDIES; DISEASES IN TWINS; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; NEUROPEPTIDES; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PREGNANCY; PROPIONIBACTERIUM ACNES; RISK FACTORS; SOCIAL ENVIRONMENT; TOLL-LIKE RECEPTORS; YOUNG ADULT;

EID: 77951470870     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2009.07168.x     Document Type: Article

References (83)

1. Zouboulis CC. Acne: Sebaceous gland action. Clin Dermatol 2004; 22: 360-366
2. Ghodsi SZ, Orawa H, Zouboulis CC. Prevalence, severity and severity risk factors of acne in high school pupils: A community-based study. J Invest Dermatol 2009; Epub ahead of print.
3. Zouboulis CC, Eady A, Philpott M, Goldsmith LA, Orfanos C, Cunliffe WC, Rosenfield R. What is the pathogenesis of acne? Exp Dermatol 2005; 14: 143-152
4. Zouboulis CC. Moderne Aknetherapie. Akt Dermatol 2003; 29: 49-57.
5. Zouboulis CC. Acne: Current aspects on pathology and treatment. Dermatol Experiences 1999; 1: 6-37.
6. Chiu A, Chon SY, Kimball AB. The response of skin disease to stress: changes in the severity of acne vulgaris as affected by examination stress. Arch Dermatol 2003; 139: 897-900. (Pubitemid 36898925)
7. Zouboulis CC, Böhm M. Neuroendocrine regulation of sebocytes - a pathogenetic link between stress and acne. Exp Dermatol 2004; 13 (Suppl 4): 31-35 (Pubitemid 39654439)
8. Melnik BC. Milk - The promoter of chronic Western diseases. Med Hypotheses 2009; 72(6): 631-639
9. Green J. Sinclair RD. Perceptions of acne vulgaris in final year medical student written examination answers. Australas J Dermatol 2001; 42: 98-101. (Pubitemid 32436761)
10. Kurokawa I, Danby FW, Ju Q, Wang X, Xiang LF, Xia L, Chen W, Nagy I, Picardo M, Suh DH, Ganceviciene R, Schagen S, Tsatsou F, Zouboulis CC. New developments in our understanding of acne pathogenesis and treatment. Exp Dermatol 2009; Epub ahead of print.
11. Herane M I, Ando I. Acne in infancy and acne genetics. Dermatology 2003; 206: 24-28
12. Goulden V, McGeown CH, Cunliffe WJ. The familial risk of adult acne: a comparison between first-degree relatives of affected and unaffected individuals. Brit J Dermatol 1999; 141: 297-300. (Pubitemid 29397999)
13. Walton S, Wyatt EH, Cunliffe WJ. Genetic control of sebum excretion and acne - a twin study. Brit J Dermatol 1988; 118:393-396
14. Kirk KM, Evans DM, Farthing B, Martin NG. Genetic and environmental influences on acne in adolescent twins. Twin Res 2001; 4:190.
15. Bekaert C, Song M, Delvigne A. Acne neonatorum and familial hyperandrogenism. Dermatology 1998; 196: 453-454
16. Ostlere LS, Rumsby G, Holownia P, Jacobs HS, Rustin MHA, Honour JW. Carrier status for steroid 21-hydroxylase deficiency is only one factor in the variable phenotype of acne. Clin Endocrinol 1998; 48: 209-215 (Pubitemid 28091053)
17. Bataille V, Snieder H, MacGregor A J, Sasieni P, Spector TD. The influence of genetics and environmental factors in the pathogenesis of acne: a twin study of acne in women. J Invest Dermatol 2002; 119: 1317-1322 (Pubitemid 36005615)
18. Stewart ME, Grahek MO, Cambier LS,Wertz PW, Downing DT Dilutional effect of increased sebaceous gland activity on the proportion of linoleic acid in sebaceous wax esters and in epidermal acylceramides. J Invest Dermatol 1986; 87: 733-736
19. Pochi PE, Strauss JS. Sebaceous gland response in man to the administration of testosterone, delta-4-androstenedione, and dehydroisoandrosterone. J Invest Dermatol 1969; 52: 32-36
20. Chen W Yang CC, Liao CY, Hung CL, Tsai SJ, Chen KF, Sheu HM, Zouboulis CC. Expression of sex-determining genes in human sebaceous glands and their possible roles in pathogenesis of acne. J Eur Acad Dermatol Venereol 2006; 20: 846-852
21. Cunliffe W, Forster R. Androgen control of the pilosebaceous duct? Brit J Dermatol 1987; 116: 449.
22. Zouboulis CC. The sebaceous gland in adolescent age. Eur J Ped Dermatol 2008; 18: 150-154
23. Thiboutot D, Knaggs H, Gilliland K, Lin G. Activity of 5-alpha-reductase and 17-beta-hydroxysteroid dehydrogenase in the infrainfundibulum of subjects with and without acne vulgaris. Dermatology 1998; 196: 38-42. (Pubitemid 28116035)
24. Lucky AW Biro FM, Huster GA, Leach AD, Morrison JA, Ratterman J. Acne vulgaris in premenarchal girls. Arch Dermatol 1994; 130: 308-314
25. Stewart ME, Downing DT, Cook JS, Hansen JR, Strauss JS. Sebaceous gland activity and serum dehydroepiandrosterone sulfate levels in boys and girls. Arch Dermatol 1992; 128: 1345-1348
26. Marynick SP, Chakmajian ZH, McCaffree DL, Herdon JH. Androgen excess in cystic acne. N Engl J Med 1983;308:981-986
27. Schmidt JB, Spona J, Huber J. Androgen receptor in hirsutism and acne. Gynecol Obstet Invest 1986; 22: 206-211
28. Thiboutot D, Harris G, lies V, Cimis G, Gilliland K, Hagari S. Activity of the type 1 5 alpha-reductase exhibits regional differences in isolated sebaceous glands and whole skin. J Invest Dermatol 1995; 105: 209-214
29. Zouboulis CC. Therapie der Akne mit Antiandrogenen - Eine evidenzbasierte Übersicht. J Dtsch Dermatol Ges 2003; 1:535-546
30. Imperato-McGinley J, Gautier T, Cai LQ Yee B, Epstein J, Pochi P. The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity. J Clin Endocrinol Metabol 1993;76:524-528 (Pubitemid 23073086)
31. Rosenfield RL, Deplewski D, Kentsis A, Ciletti N. Mechanisms of androgen induction of sebocyte differentiation. Dermatology 1998; 196: 43-46 (Pubitemid 28116036)
32. Makrantonaki E, Zouboulis CC. Testosterone metabolism to 5a-dihydrotestosterone and synthesis of sebaceous lipids is regulated by the peroxisome proliferators-activated receptor ligand linoleic acid in human sebocytes. Br J Dermatol 2007; 156: 428-432 (Pubitemid 46253937)
33. Fimmel S, Saborowski A, Térouanne B, Sultan C, Zouboulis CC. Inhibition of the androgen receptor by antisense oligonucleotides regulates the biological activity of androgens in SZ95 sebocytes. Horm Metab Res 2007; 39: 149-156 (Pubitemid 46535573)
34. Chen W, Yang C-C, Sheu H-M, Seltmann H, Zouboulis CC. Expression of peroxisome proliferator-activated receptor and CCAAT/enhancer binding protein transcription factors in cultured human sebocytes. J Invest Dermatol 2003; 121:441-447 (Pubitemid 37072251)
35. 2 are active in sebaceous glands. J Mol Med 2006; 84: 75-87.
36. Wróbel A, Seltmann H, Fimmel S, Müller-Decker K, Tsukada M, Bogdanoff B, Mandt N, Blume-Peytavi U, Orfanos CE, Zouboulis CC. Differentiation and apoptosis in human immortalized sebocytes. J Invest Dermatol 2003; 120: 175-181 (Pubitemid 36513064)
37. Zouboulis CC, Nestoris S, Adler YD, Picardo M, Camera E, Orth M, Orfanos CE, Cunliffe WJ. A new concept for acne therapy: a pilot study with zileuton, an oral 5-lipoxygenase inhibitor. Arch Dermatol 2003; 139: 668-670 (Pubitemid 36576390)
38. Zouboulis CC, Saborowski A, Boschnakow A. Zileuton, an oral 5-lipoxygenase inhibitor, directly reduces sebum production. Dermatology 2005; 210:36-38 (Pubitemid 39656717)
39. Trivedi NR, Cong Z, Nelson AM, Albert AJ, Rosamilia LL, Sivarajah S, Gilliland KL, Liu W, Mauger DT, Gabbay RA, Thiboutot DM. Peroxisome proliferator-activated receptors increase human sebum production. J Invest Dermatol 2006; 126: 2002-2009 (Pubitemid 44244843)
40. Norris JF, Cunliffe WJ. A histological and immunocytochemical study of early acne lesions. Brit J Dermatol 1988; 118:651-659
41. Cunliffe WJ, Holland DB, Clark SM, Stables GI. Comedogenesis: some new etiological, clinical and therapeutic strategies. Br J Dermatol 2000; 142: 1084-1091
42. Jeremy AHT, Holland DB, Roberts SG, Thomson KF, Cunliffe WJ. Inflammatory events are involved in acne lesion initiation. J Invest Dermatol 2003;121:20-27
43. Zouboulis CC. Is acne vulgaris a genuine inflammatory disease? Dermatology 2001; 203: 277-279
44. Ingham E, Eady EA, Goodwin CE, Cove JH, Cunliffe WJ. Pro-inflammatory levels of interleukin-1 alpha-like bioactivity are present in the majority of open comedones in acne vulgaris. J Invest Dermatol 1992; 98: 895-901.
45. Zouboulis CC, Xia L, Akamatsu H, Seltmann H, Fritsch M, Hornemann S, Ruhl R, Chen W, Nau H, Orfanos CE. The human sebocyte culture model provides new insights into development and management of seborrhoea and acne. Dermatology 1998; 196: 21-31. (Pubitemid 28116033)
46. Antilla HS, Reitamo S, Saurat JH. Interleukin 1 immunoreactivity in sebaceous glands. Brit J Dermatol 1992; 127: 585-588
47. Boehm KD, Yun JK, Strohl KP, Elmets CA. Messenger RNAs for the multifunctional cytokines interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor-alpha are present in adnexal tissues and in dermis of normal human skin. Exp Dermatol 1995; 4: 335-341
48. Guy R, Green M, Kealey T. Modeling of acne in vitro. J Invest Dermatol 1996; 106:176-182
49. Toyoda M, Nakamura M, Makino T, Kagoura M, Morohashi M. Sebaceous glands in acne patients express high levels of neutral endopeptidase. Exp Dermatol 2002; 11: 241-247 (Pubitemid 36934654)
50. Thielitz A, Reinhold D, Vetter R, Lendeckel U, Kähne T, Bank U, Helmuth M, Neubert K, Faust J, Hartig R, Wrenger S, Zouboulis CC, Ansorge S, Gollnick H. Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD 13) target major pathogenetic steps in acne initiation. J Invest Dermatol 2007; 127: 1042-1051 (Pubitemid 46625127)
51. Zouboulis CC, Seltmann H, Hiroi N, Chen W, Young M, Oeff M, Scherbaum WA, Orfanos CE, McCann SM, Bornstein SR. Corticotropin releasing hor- mone: an autocrine hormone that promotes lipogenesis in human sebocytes. Proc Natl Acad Sci USA 2002; 99: 7148-7153 (Pubitemid 34526270)
52. Böhm M, Schiller M, Stander S, Seltmann H, Li Z, BrzoskaT, Metze D, Schiöth HB, Skottner A, Selffert K, Zouboulis CC, Luger TA. Evidence for expression of melanocortin-1 receptor in human sebocytes in vitro and in situ. J Invest Dermatol 2002; 118: 533-539 (Pubitemid 34227173)
53. Krause K Schnitger A, Fimmel S, Glass E, Zouboulis CC. Corticotropin-releasing hormone skin signalling is receptor-mediated and is predominant in the sebaceous glands. Horm Metab Res 2007; 39: 166-170 (Pubitemid 46535575)
54. Ganceviciene R, Graziene V, Fimmel S, Zouboulis CC. Involvement of the corticotropin-releasing hormone system in the pathogenesis of acne vulgaris. Br J Dermatol 2009; 160: 345-352
55. Alesci S, Bornstein SR. Neuroimmunoregulation of androgens in the adrenal gland and the skin. Horm Res 2000; 54: 281-286 (Pubitemid 34701734)
56. Slominski AT, Botchkarev V, Choudhry M, Fazal N, Fechner K, Furkert J, Krause E, Roloff B, Sayeed M, Wei E, Zbytek B, Zipper J, Wortsman J, Paus R. Cutaneous expression of CRH and CRH-R. Is there a "skin stress response system?". Ann NY Acad Sci 1999; 885: 287-311.
57. Zouboulis CC. The human skin as a hormone target and an endocrine gland. Hormones 2004; 3: 9-26.
58. Letawe C, Boone M, Pierard GE. Digital image analysis of the effect of topically applied linoleic acid on acne microcomedones. Clin Exp Dermatol 1998; 23:56-58 (Pubitemid 28308364)
59. Zhang Q, Seltmann H, Zouboulis CC, Konger RL. Involvement of PPAR-gamma in oxidative stress-mediated prostaglandin E2 production in SZ95 human sebaceous gland cells. J Invest Dermatol 2006; 126: 42-48 (Pubitemid 43336092)
60. Schaefer O. When the Eskimo comes to town. Nutr Today 1971; 6: 8-16.
61. Steiner PE. Necropsies on Okinawans: anatomic and pathologic observations. Arch Pathol 1946; 42: 359-380
62. Simopoulos AP. Evolutionary aspects of diet and essential fatty acids. World Rev Nutr Diet 2001; 88: 18-27. (Pubitemid 33210309)
63. Adebamowo CA, Spiegelman D, Berkey CS, Danby FW, Rockett HH, Colditz GA, Willen WC, Holmes MD. Milk consumption and acne in teenaged boys. J Am Acad Dermatol 2008; 58: 787-793
64. Smith RN, Mann NJ, Braue A, Mäkeläinen H, Varigos GA. A lowglycemic-load diet improves symptoms in acne vulgaris patients: a randomized controlled trial. Am J Clin Nutr 2007; 86: 107-115 (Pubitemid 47041599)
65. Cordain L, Lindeberg S, Hurtado M, Hill K, Eaton SB, Brand-Miller J. Acne vulgaris: a disease of Western civilization. Arch Dermatol 2002; 138: 1584-1590 (Pubitemid 35453471)
66. Thiboutot DM, Strauss JS. Diet and acne revisited. Arch Dermatol 2002; 138: 1591-1592
67. Schäfer T, Nienhaus A, Vieluf D, Berger J, Ring J. Epidemiology of acne in the general population: the risk of smoking. Brit J Dermatol 2001; 145: 100-104 (Pubitemid 32862794)
68. Firooz A, Sarhangnejad R, Davoudi SM, Nassiri-Kashani M. Acne and smoking: is there a relationship? BMC Dermatol 2005; 5: 2.
69. Galobardes B, Davey Smith G, Jeffreys M, Kinra S, McCarron P. Acne in adolescence and cause-specific mortality: lower coronary heart disease but higher prostate cancer mortality: the Glasgow Alumni Cohort Study. Am J Epidemiol 2005; 161: 1094-1101 (Pubitemid 40847336)
70. Klaz I, Kochba I, Shohat T, Zarka S, Brenner S. Severe acne vulgaris and tobacco smoking in young men. J Invest Dermatol 2006; 126: 1749-1752 (Pubitemid 44086508)
71. Tithof P K, Elgayyar M, Cho Y, Guan W, Fisher AB, Peters-Golden M. Polycyclic aromatic hydrocarbons present in cigarette smoke cause endothelial cell apoptosis by a phospholipase A2-dependent mechanism. FASEB J 2002; 16: 1463-1464
72. Zouboulis CC. Human skin: An independent peripheral endocrine organ. Horm Res 2000; 54: 230-242
73. Thompson RL, Pyke S, Scott EA, Thompson SG, Wood DA. Cigarette smoking, polyunsaturated fats, and coronary heart disease. Ann N Y Acad Sci 1993; 686: 130-138 (Pubitemid 23204422)
74. Kim J, Ochoa MT, Krutzik SR, Takeuchi O, Uematsu S, Legaspi AJ, Brightbill HD, Holland D, Cunliffe WJ, Akira S, Sieling PA, Godowski PJ, Modlin RL. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol 2002; 169: 1535-1541 (Pubitemid 34809200)
75. Pivarcsi A, Bodai L, Rethi B, Kenderessy-Szabo A, Koreck A, Szell M, Beer Z, Bata-Csorgoo Z, Magocsi M, Rajnavolgyi E, Dobozy A, Kemeny L. Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int Immunol 2003; 15: 721-730 (Pubitemid 36675803)
76. Ingham E, Walters CE, Eady EA, Cove JH, Kearney JN, Cunliffe WJ. Inflammation in acne vulgaris: failure of skin micro-organisms to modulate keratinocyte interleukin 1 alpha production in vitro. Dermatology 1998; 196: 86-88 (Pubitemid 28116049)
77. Nagy I, Pivarcsi A, Koreck A, Szell M, Urban E, Kemény L. Distinct strains of Propionibacterium acnes induces selective human ß-defensin-2 and interleukin-8 expression in human keratinocytes through Toll-like receptors. J Invest Dermatol 2005; 124: 931-938 (Pubitemid 40629093)
78. OeffMK, Seltmann H, Hiroi N, Nastos A, Makrantonaki E, Bornstein SR, Zouboulis CC. Differential regulation of Toll-like receptor and CD 14 pathways by retinoids and corticosteroids in human sebocytes. Dermatology 2006; 213: 266. (Pubitemid 44567850)
79. Seltmann H, Zouboulis CC. Human sebocytes express CD 14 molecules and their IL8 production is induced by both CD14-dependent and independent pathways. J Invest Dermatol 2001; 117:804.
80. Georgel P, Crozat K, Lauth X, Makrantonaki E, Seltmann H, Sovath S, Hoebe K, Du X, Rutschmann S, Jiang Z, Bigby T, Nizet V, Zouboulis CC, Beutler B. A TLR2-responsive lipid effector pathway protects mammals against Gram-positive bacterial skin infections. Infect Immun 2005; 73: 4512-4521 (Pubitemid 41105605)
81. Nagy I, Pivarcsi A, Kis K, Koreck A, Bodai L, McDowell A, Seltmann H, Patrick S, Zouboulis CC, Kemény L. Propionibacterium acnes and LPS induce the expression of antibacterial peptides and proinflammatory cytokines/chemokines in human sebocytes. Microbes Infect 2006; 8: 2195-2205 (Pubitemid 44335873)
82. Lee D-Y, Yamasaki K, Rudsil J, Zouboulis CC, Park GT, Yang J-M, Gallo RL. Sebocytes express functional cathelicidin antimicrobial peptides and can act to kill Propionibacterium acnes. J Invest Dermatol 2008; 128: 1863-1866 (Pubitemid 351847367)
83. Ganceviciene R, Fimmel S, Glass E, Zouboulis CC. Psoriasin and follicular hyperkeratinization in acne comedones. Dermatology 2006; 213: 270-272 (Pubitemid 44567852)